ArticleFrontiers in immunology2021

Good Tumor Response to Chemoradioimmunotherapy in dMMR/MSI-H Advanced Colorectal Cancer: A Case Series.

Chengjing Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.